loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Chongqing Zhifei Biological Products

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 Liraglutide (1)

02 Semaglutide (1)

filter

01 Chongqing Zhifei Biological Products (2)

filter

01 China (2)

URL Supplier Web Content
Chongqing Zhifei Biological Products Co., Ltd. is an international high-tech biopharmaceutical enterprise integrating vaccine and biological product R&D, production, sales, distribution, and import and export. The development prospect is broad. In September 2010, it was listed on the Shenzhen Stock Exchange (stock code: 300122), becoming the first ...
Chongqing Zhifei Biological Products Co., Ltd. is an international high-tech biopharmaceutical enterprise integrating vaccine and biological product R&D, production, sales, distribution, and import and export. The development prospect is broad. In September 2010, it was listed on the Shenzhen Stock Exchange (stock code: 300122), becoming the first privately-owned vaccine company listed on the Growth Enterprise Market. It has five wholly-owned subsidiaries and two joint-stock companies, including Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. and Anhui Zhifeilong Koma Biopharmaceutical Co., Ltd. are high-tech enterprises.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Chongqing Zhifei Biological Products Co., Ltd. is an international high-tech biopharmaceutical enterprise integrating vaccine and biological product R&D, production, sales, distribution, and import and export. The development prospect is broad. In September 2010, it was listed on the Shenzhen Stock Exchange (stock code: 300122), becoming the first ...
Chongqing Zhifei Biological Products Co., Ltd. is an international high-tech biopharmaceutical enterprise integrating vaccine and biological product R&D, production, sales, distribution, and import and export. The development prospect is broad. In September 2010, it was listed on the Shenzhen Stock Exchange (stock code: 300122), becoming the first privately-owned vaccine company listed on the Growth Enterprise Market. It has five wholly-owned subsidiaries and two joint-stock companies, including Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. and Anhui Zhifeilong Koma Biopharmaceutical Co., Ltd. are high-tech enterprises.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY